{"name":"Staidson (Beijing) Biopharmaceuticals Co., Ltd","slug":"staidson-beijing-biopharmaceuticals-co-ltd","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Oncology","slug":"oncology","revenue":0,"percentOfTotal":0,"drugCount":2,"colorKey":"oncology","drugs":[{"name":"BDB-001 injection","genericName":"BDB-001 injection","slug":"bdb-001-injection","indication":"Metastatic non-small cell lung cancer","status":"phase_3"},{"name":"STSA-1002 injection","genericName":"STSA-1002 injection","slug":"stsa-1002-injection","indication":"Non-small cell lung cancer, PD-L1 positive","status":"phase_3"}]},{"name":"Infectious Disease","slug":"infectious-disease","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"immunology","drugs":[{"name":"STSP-0601 for Injection","genericName":"STSP-0601 for Injection","slug":"stsp-0601-for-injection","indication":"Chronic hepatitis B","status":"phase_3"}]}],"pipeline":[{"name":"BDB-001 injection","genericName":"BDB-001 injection","slug":"bdb-001-injection","phase":"phase_3","mechanism":"BDB-001 injection is a monoclonal antibody targeting a specific molecular target.","indications":["Metastatic non-small cell lung cancer"],"catalyst":""},{"name":"STSP-0601 for Injection","genericName":"STSP-0601 for Injection","slug":"stsp-0601-for-injection","phase":"phase_3","mechanism":"STSP-0601 is a recombinant human serum albumin-interferon alpha fusion protein that enhances antiviral and immunomodulatory responses.","indications":["Chronic hepatitis B","Chronic hepatitis C"],"catalyst":""},{"name":"STSA-1002 injection","genericName":"STSA-1002 injection","slug":"stsa-1002-injection","phase":"phase_3","mechanism":"STSA-1002 injection is a monoclonal antibody targeting the PD-1 receptor.","indications":["Non-small cell lung cancer, PD-L1 positive"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMixwFBVV95cUxOZmVjTC13dVZfNko0RWQ5ZzB2OVF2M3VTXzloQk1obkU1SEhhRk5KdFNISGxJak9CeGpHZHFMWXhXMFAtREdGQWNfblRwZll2SUNjT1k5cFdUVF9uZG9EZlp2RHZPaW5zN2owa3NWQU1NcnJiaWU2M3h6TGRSNEU5emwtb041emVUbVNmYk8wVUVMRzNQWVZZdndhYXoyS1hYQ0dqV0YtSVV2TFJxY3h6QVlmbVBNcjRjVHBpLUpmM3lfaV9UU1Fj?oc=5","date":"2026-03-30","type":"pipeline","source":"Markets Mojo","summary":"Staidson Biopharmaceuticals Hits Day High with 20% Surge in Stock Price - Markets Mojo","headline":"Staidson Biopharmaceuticals Hits Day High with 20% Surge in Stock Price","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi5wFBVV95cUxNWUdwNjhsNXZONHcxc213QVRJaE1QU2o3cXoxRGd3TUMzMVUwdERpR1hESlR0eHNkNWxnVHdRQ3pDeW12SnR2U0ZaWXN3S3NlVnV6bDRFMlFYQjJtaHYxeWh3Y0otQXRJc2NyX0FneGxacl92ZjJ0bjJldW1LaDJYd1FTdFlsZGRjcEZCSndWQjFBNHJnU3l3WnBuY19JeEpaMFo4ZUs1a05jeXVUdnpvM1J0TlF0c2dFN2lNMXM4WFZZLU02bW1CMnRVaGhnWmxmWGVINElrN2ktbW00SGlNOFhZbXhsVm8?oc=5","date":"2026-03-30","type":"pipeline","source":"Markets Mojo","summary":"Shanghai Composite Rises 0.63% as Staidson Biopharmaceuticals Soars 20.02% Amid Bullish Sentiment - Markets Mojo","headline":"Shanghai Composite Rises 0.63% as Staidson Biopharmaceuticals Soars 20.02% Amid Bullish Sentiment","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimwFBVV95cUxONGFpRVkwTTNZMUlaRzFxZWFVSWdhbHdOZGRTTDdVbWhueFNuRWF0X3NEa3ZLc0hzRzBwbHQ4eE1wVWFrMFlxV2NBZUlMeDJkRGJlVXkwWGp2Q2YzUFRpVUk2cXlaMjBhbkpVN2JOcjhWc3lSLWhnRHpBNE5STERPSUpJWVdMdGJ5QUpSTzgtX3NYZjMxeHpLRklvRQ?oc=5","date":"2026-03-19","type":"pipeline","source":"openPR.com","summary":"Acute Respiratory Distress Syndrome Pipeline 2026: Therapies - openPR.com","headline":"Acute Respiratory Distress Syndrome Pipeline 2026: Therapies","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiygFBVV95cUxQMGFRdVBkVE1ZbmFNOGxJdTZTcVIxOE5xamNUM2JFSU12NXlvNmRUN1plbmZDUGdxSjRibVB5SC14aHg3Q1VOMkRTSmczMTZCN3FaeTFLd0gzMkluYVM2cnhIZjFJNzJrc1BGNFhWVWNHZDRRZ2RfNmw2UHByM0NxVUFxR19iNFJQdWJhWFA1WFotMW1qSXA4NFZnY25hNUtGa0dSUlhnb0t1Y0RWbjhTbHUtZ0dmSklLeTFDSjk2NHNjTGxVMGN0MS1n?oc=5","date":"2026-03-13","type":"pipeline","source":"Markets Mojo","summary":"Staidson Biopharmaceuticals Hits Day Low Amid Price Pressure at CNY 24.96 - Markets Mojo","headline":"Staidson Biopharmaceuticals Hits Day Low Amid Price Pressure at CNY 24.96","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi3AFBVV95cUxPZGFDeEtITEVMQXV0ZHczcEx1NW4ybWx5X1BLNE1ZaGM1YXZJcjhaVXQ0S0Q1OEhBNW9PVkRkbUlQV3VYeW9ybHlTWnBaN2dKMkVXNF9iUFdzUnphSEJCODZzc2ZzenAzazRTWDdvRWg5OW9jR0FUWDA1WU5VcWxvNEY0N1Z0MjB1RFdrNko2dUplVDhJMHgzRXRPbmtBSmQ0QVJJMTY2cFhMZFNGMno4M2t1WHllRzEtY3FVZU9qSjlvREdjVmJTaEFZRnVYQTVmRWk3Y3FMSVlxM2VQ?oc=5","date":"2026-03-04","type":"pipeline","source":"prnewswire.com","summary":"Global Orphan Drugs Market is Anticipated to Cross USD 350 Billion by 2032 | DelveInsight - prnewswire.com","headline":"Global Orphan Drugs Market is Anticipated to Cross USD 350 Billion by 2032 | DelveInsight","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivgJBVV95cUxQck9IdmdhSWsza0ZVT0ZaeDVEWHROX2poanB4UEk0aGpiUDFhSzUwTHhoVm1leHV5SnBXejdsT2JCZ2dQdnpKYnJZXy14cl94ZmR1SDRERURUMHlrbERRdjVNd2t1MWg4QjRpUWV0Y1pVd0poN3hnQzFoM2NFX0tVbGEzSkE3RXdXUUYxck5OTXZFdUZ3UzdEX1hSQkhVMk0xYnhMT2lwenBKT2dtSWpscDIyRjFiek1sbWRVWW1vUGtzS2xreHJtWWlmSUt4ZnAyVG1XWWV3c0xzLUxtVXJ0ZWN1cFdMVWtkZ0xlbWJIR25yYVc0V2NXVmFtR2ROMmRlTVktRUhtcm8xZWM2VHlhMHZzR0VqZmVfNHNxeS1GX2pNaWhXbDh3dEpZNjNVVXVlY21hQzYwdHdTbEdtV3c?oc=5","date":"2025-12-17","type":"pipeline","source":"PR Newswire UK","summary":"Ulcerative Colitis Market Poised for Strong Expansion During the Forecast Period (2025-2034) Driven by Biologic and Novel Therapy Adoption Landscape | DelveInsight - PR Newswire UK","headline":"Ulcerative Colitis Market Poised for Strong Expansion During the Forecast Period (2025-2034) Driven by Biologic and Nove","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi1wJBVV95cUxNYW83TTltR0ZURmh0TjhVWVpEMUsyX1B6RnRfLVJRSHZKbjVWdWE4a1d5ejJmT2hueGFDVXpwS0FlamtteVlFbmdHSU5uTnQwNjdlY0JkQjB2eVdoOHRacUtTRktnd3c0c3lqeUtuOUdKaWxvNUIzVVhvSDc4LUV2N1NRZjJuTDVHUWkxYm1pOFFoelJyUlExUXFHemg1M3IxUnRTWjBRWHNUSVg1QTFZRldFdF9FMlU5SC1XVXJoSzZuUkJSN0didEZDY1lfNFdhUjBMczZiQkNuQ293ck9xaVFLM1U1UzB3YUVhYUF2T1U5UFNmMmZVbUVHWERqRmwwSXpfdDZwZElqSGVaaV9vRzNfQndqOHV6MHhNM0psWWM5dkxZeUxJMzEtT2R1WHFubVdNTkhUZWEzYjBwOG9idFg5MHJodzZaTTEzN3JxRUNOclhwU1Nj?oc=5","date":"2025-11-06","type":"pipeline","source":"GlobeNewswire","summary":"Global Oxygen Therapy Equipment Market is Predicted to - GlobeNewswire","headline":"Global Oxygen Therapy Equipment Market is Predicted to","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiogJBVV95cUxQUlBEN2JQMkVlejVsUDE0d0pQcXhDTHBHdE1nMmhzTVNERFBfTDkzWW83Yi1ZZEpBbHowUjA1S0VpNnJ2NXZnUHRJY09NUDVxZnp2WFNxc1I2Q0x3dTFldXhFNm5JUDR5MlA4a0tDeTUxYm5WYTZMVzZUczJHYjBHbDFFaDRiTDZTSlJNRzFnbHBjNUYwNkR3ejJGa3AweDlpeVdhdk5ucGJmSHctSTdHS3g5N2lMYU1fMDB3TlYtUlBScG4zYUI4bk5LQjVlaGt3blZ5OWRfdkVCY2NFcWYtZ1UxVGxrZWJtZExQSGxFYUN4c1ZSQWhaZkxhT1M1RXRudlNuRXNlMXQ3MzFPMkZTeFRvS3VVaHprWlpsazd1akZOUQ?oc=5","date":"2024-11-06","type":"trial","source":"prnewswire.com","summary":"Severe Asthma Clinical Trial Pipeline Appears Robust With 40+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight - prnewswire.com","headline":"Severe Asthma Clinical Trial Pipeline Appears Robust With 40+ Key Pharma Companies Actively Working in the Therapeutics ","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi_wFBVV95cUxObHRZbW5qbUhROVktVlZwYWNoYjRlVEtjME5JVzlWRzFqdlhpLXljMk5BWmRqNXZXbmhpTFpHWlR1QmYtbm5WVEJwQ0xfaVFrTnhvRGNNMnkteHpmRGVvTTNYSnRjY3ZFa0QtLXVSX1Q3VFJLOUFtUTRQTTdhX3ZfWHJ5ZlIwRldIT1VpaER0ZndiekZ0akJvOFZPNFlfb21fU1pFQ0pwNVJqdXRNZVRKTDVCQnZJXy1VVWFTQlE0S0ZzVjRKdW1IVWx3WTdJSERaNzk3alM3Zk53Mmd5QWpRcEQzcEdJWVJ0RktSalJXUGRtZk9reGVTbnhkMmo0SlE?oc=5","date":"2024-08-07","type":"pipeline","source":"GlobeNewswire","summary":"Global Respiratory Drugs Market to Register Incremental Growth at a CAGR of ~6% by 2030 | DelveInsight - GlobeNewswire","headline":"Global Respiratory Drugs Market to Register Incremental Growth at a CAGR of ~6% by 2030 | DelveInsight","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirgJBVV95cUxPT3JSZnFNM21LVkg5MmM0QkNPc0JVN1NNak5mUHdjdHFaejdNSFFBal82cXdVVEZtb0gxUWVNeWJ2OVR5bmhrMXFNX2NHWlVWblk2cXFrbU5kaDNfclNTWDBPMG44ZmZSdE5QVm1HeER4dWVHS3BtM280bTFvclotWjk0QUhldEVCcU00UGY0SkM1eEI0cGU5T3hGZ3dySFlQdW0wbTBGcmp2REFYdG14bkgycEhIYmMzZ0M4M0d6cWNfcmdaWmNmcDN2SzlvdGFlTXRQZmJNX0N1cUJsTDhMVkUtYUtBWjlFbkgtdUFYaS1ocW5JWnFXUXF2eFF1U1BnZ1E0Q1d4dEc1YVV6aTNjQ2FFai1VZlppQ19GSmV5Q19mWk1GVENyT2g0amRvZw?oc=5","date":"2023-11-21","type":"pipeline","source":"The Malaysian Reserve","summary":"Key Market Analysis of Sickle Cell Disease, Fanconi Anemia, and Diamond-Blackfan Anemia in the Inherited Types of Anemia Therapeutic Space | Insights by DelveInsight - The Malaysian Reserve","headline":"Key Market Analysis of Sickle Cell Disease, Fanconi Anemia, and Diamond-Blackfan Anemia in the Inherited Types of Anemia","sentiment":"neutral"}],"patents":[],"drugCount":3,"phaseCounts":{"phase_3":3},"enrichmentLevel":0,"visitCount":3,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}